Aurlide Ltd. is a Finnish biotech company, service provider, and strategic partner specializing in computer-aided drug discovery and development (CADD). We offer our in silico expertise throughout all stages of preclinical drug development, from target validation to lead optimization and beyond. 

Our expertise spans from rational discovery and development of small molecules and macrocycles to first-in-class protein-protein interaction modulators. We also apply predictive toxicology and pharmacokinetics to ensure the success of our clients' drug candidates. 
Driven by our advanced technology and expertise, we’ve also initiated our own drug discovery projects, pushing the boundaries of therapeutic innovation and creating new opportunities for breakthrough treatments. 

Looking to innovate? Reach out, and let's explore how we can collaborate!

"Aurlide – Your molecule, discovered!"

Our achievements, shortly:
13 patents (as inventors)
5 clinical candidates for our customers
2 out-licensed PPI modulator discovery projects
100+ publications

Aurlide ltd.

Org chart

Teams

Offices